Mario Santinami

Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma

Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2017 · 1.5K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients

Mariantonia Logozzi, Angelo De Milito, Luana Lugini et al. · PLoS ONE · 2009 · 966 citations · Full text

Medicine, Cell Biology, Oncology +17

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial

N. Cascinelli, Alberto Morabito, Mario Santinami et al. · The Lancet · 1998 · 648 citations

Medicine, Oncology, Surgery +13

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

Alexander M.M. Eggermont, Stefan Suciu, Mario Santinami et al. · The Lancet · 2008 · 642 citations

Medicine, Oncology, Pharmacotherapy +14

Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

Arianna Calcinotto, Paola Filipazzi, Matteo Grioni et al. · Cancer Research · 2012 · 623 citations

Life Sciences, Immunology, Oncology +17